Home » Topics » BioWorld Science

BioWorld Science
RSS

Stingray Therapeutics presents new ENPP1 inhibitors

Sep. 3, 2021

Haim Bio synthesizes new antiepileptics

Sep. 3, 2021

Bristol Myers Squibb presents PADI4 inhibitors

Sep. 3, 2021

AMMS patents carbonic anhydrase inhibitors

Sep. 3, 2021

Study identifies cell state as oncogene enabler

Sep. 3, 2021

Thymic stromal lymphopoietin and T cells shown to homeostatically regulate sebum production

Sep. 3, 2021

2,3-Disubstituted pyridine IDO1 inhibitors with improved drug-like properties

Sep. 3, 2021

miR-7-5p and miR-375-3p: new circulating markers of pituitary NETs

Sep. 3, 2021

JDQ-443: a mutant-selective, irreversible inhibitor of KRAS G12C with an unprecedented binding mode

Sep. 3, 2021

New Drosophila model casts light on cancer cachexia

Sep. 2, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...